With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- “Choosing between career and family? That’s not true. I have 7 children and I am president of the European Commissio Jul 14, 2021
- Erick Mendoza, ex-husband of Magaly Solier: ” To hurt her is to hurt my children ” Aug 31, 2021
- “The program of Petro and France vindicates the role of the public sector in fundamental rights in health and education”: CUT Jun 1, 2022
- Consuelo Duval confirmed that she tested positive for COVID-19: “My world fell apart” Sep 21, 2020
- “Dubai Endowments” implements endowment projects worth 148 million dirhams Sep 26, 2021
- The United States condemned the new Iraqi law that criminalizes relations with Israel May 27, 2022
- He beat Mane !: Elettra Lamborghini got married and none of the members of “Acapulco Shore” were at the wedding Sep 27, 2020